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ORIGINAL ARTICLE
Rare disruptive variants in the DISC1 Interactome and
Regulome: association with cognitive ability and schizophrenia
S Teng1,2,10, PA Thomson3,4,10, S McCarthy1,10, M Kramer1, S Muller1, J Lihm1, S Morris3, DC Soares3, W Hennah5, S Harris3,4,
LM Camargo6, V Malkov7, AM McIntosh8, JK Millar3, DH Blackwood8, KL Evans4, IJ Deary4,9, DJ Porteous3,4 and WR McCombie1
Schizophrenia (SCZ), bipolar disorder (BD) and recurrent major depressive disorder (rMDD) are common psychiatric illnesses. All
have been associated with lower cognitive ability, and show evidence of genetic overlap and substantial evidence of pleiotropy
with cognitive function and neuroticism. Disrupted in schizophrenia 1 (DISC1) protein directly interacts with a large set of proteins
(DISC1 Interactome) that are involved in brain development and signaling. Modulation of DISC1 expression alters the expression of
a circumscribed set of genes (DISC1 Regulome) that are also implicated in brain biology and disorder. Here we report targeted
sequencing of 59 DISC1 Interactome genes and 154 Regulome genes in 654 psychiatric patients and 889 cognitively-phenotyped
control subjects, on whom we previously reported evidence for trait association from complete sequencing of the DISC1 locus.
Burden analyses of rare and singleton variants predicted to be damaging were performed for psychiatric disorders, cognitive
variables and personality traits. The DISC1 Interactome and Regulome showed differential association across the phenotypes tested.
After family-wise error correction across all traits (FWERacross), an increased burden of singleton disruptive variants in the Regulome
was associated with SCZ (FWERacross P = 0.0339). The burden of singleton disruptive variants in the DISC1 Interactome was
associated with low cognitive ability at age 11 (FWERacross P = 0.0043). These results identify altered regulation of schizophrenia
candidate genes by DISC1 and its core Interactome as an alternate pathway for schizophrenia risk, consistent with the emerging
effects of rare copy number variants associated with intellectual disability.
Molecular Psychiatry advance online publication, 20 June 2017; doi:10.1038/mp.2017.115
INTRODUCTION
Schizophrenia (SCZ), bipolar disorder (BD) and recurrent major
depressive disorder (rMDD) affect tens of millions of people
worldwide. These disorders are moderately heritable and family
history is a strong predictor of risk. Genome-wide association
studies (GWAS), structural variant analyses and genome sequen-
cing studies have identified that common single-nucleotide
variants (SNVs), low penetrant rare SNVs, moderate to high
penetrant copy number variants (CNVs) and potentially causal de
novomutations each play a role in the genetic etiology of SCZ and
BD and, to a lesser extent, in rMDD.1–4
There is now strong evidence for shared genetic risk across
traditional diagnostic boundaries supporting the observation of
‘mixed’ diagnoses families.5,6 GWAS studies capture common,
ancient variation and point to an additive, polygenic architecture
that transcends psychiatric diagnoses to predict cognitive ability
variables.1,7,8 Lower cognitive function, both premorbid and post-
onset, has been associated with these disorders, and recently
polygenic risk score analysis has suggested a small, but significant,
genetic correlation between risk for major mental illness and
cognitive ability.9
In a complementary fashion to common variants identified in
GWAS, rare variants have been identified that segregate with
psychiatric disorder in a quasi-Mendelian manner and impact
upon normal cognitive function.10,11 One such example is a
balanced t(1;11) (q42;q14) translocation in the Disrupted in
Schizophrenia 1 (DISC1) gene, which was identified in a large
Scottish pedigree highly burdened with SCZ, BD and rMDD.12
Independent reports of linkage and association have since reported
evidence for region-wide association of DISC1 variants, or more
commonly haplotypes, with these and other psychiatric disorders
as well as for cognitive and neuropsychological traits.13–15
Although DISC1 itself is not a GWAS significant finding, its
interactor PDE4B and regulated gene NRXN1 are reported as
significant.16,17 Convergent functional genomics approaches
integrating the functional and genotypic data continue to support
involvement of DISC1 disruption in schizophrenia and related
biological pathways.18,19
Recently, we reported deep sequencing of the DISC1 locus
(528 kb) in 1542 samples that identified 2010 rare variants, of
which ~ 60% were novel.17 We identified a common intronic
variant with region-wide association for rMDD, and a rare
missense mutation (R37W), previously reported in a SCZ case,20
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in an individual with rMDD and in additional family members with
mental disorders.17 Burden analysis also identified nominal
associations with measures of depressed mood and cognitive
ability at age 11, age 70 and cognitive ageing (change in cognitive
ability between age 11 and 70).17 Motivated by these findings, we
hypothesized that further insights might emerge from a directly
comparable study of the DISC1 pathway genes.21–24
Molecular studies have shown that DISC1 functions as a scaffold
protein that is critical in cell signaling, neuronal development and
ontogenesis through multiple protein-protein interactions.25,26
DISC1-interacting partners (DISC1 Interactome) are enriched for
proteins known to be involved in neural proliferation, migration,
signaling and synaptic function.14,21,22,24,27 Positive case-control
associations have been reported with psychiatric disorders for the
following DISC1 Interactome genes: ATF4, CIT, NDE1, PCM1, PDE4B,
PDE4D and YWHAE.14 In addition, structural rearrangements of
PDE4B and NDE1 have been reported in patients with SCZ.28,29
Sequencing studies in SCZ have examined the burden of variants
in DISC1 and its interacting partners with mixed results. Moens
et al.30 sequenced DISC1 and ten interacting genes in 486 SCZ
cases and 514 controls and observed an excess of rare missense
variants in affected individuals. Kenny et al.31 sequenced the
exons of 215 synaptic genes including DISC1 and 22 interaction
partners in 147 individuals with autism (ASD), 273 with SCZ and
287 controls. There was no enrichment of loss-of-function (LoF)
mutations in the subset of DISC1-interacting genes, but singleton
LoF variants were identified in DISC1, DMD and TRAF3IP1 in
patients with ASD. Although recent exome based studies of SCZ
did not analyze a set of DISC1-interacting genes directly, an over
representation of de novo and rare variation was observed in
genes sets such as ARC-associated scaffold protein complex at the
postsynaptic density.32 This finding suggests that the DISC1
Interactome may be enriched in genetic risk factors that function
through perturbing neuronal development and function.32
In addition to the DISC1 Interactome, disruption of the
expression of DISC1, or its interactors, has been shown to alter
the expression of a further set of genes (DISC1 Regulome).23,33,34
This gene set is enriched for neurodevelopmental, synaptogenic
and sensory perception genes as well as for registered drug
targets for psychiatric and neurological disorders.23 We selected
DISC1 Regulome genes on the basis of prior evidence of genetic
association of common variants with psychiatric illness, as well as
either: haplotype or model dependent expression patterns corre-
lated with DISC1 expression,35 DISC1 alleles23 or with DISC1 Inter-
actome genes; or proteins that directly interact with other Inter-
actome gene proteins (Supplementary Information: gene selection).
Here we report the targeted sequencing of 59 DISC1
Interactome genes (including TSNAX and DISC1) and 154 DISC1
Regulome genes in the same cohort of subjects in which the full
DISC1 locus (528 kb) was sequenced and reported.17 As for our
previous study, we report the gene-wide and gene-set burden
analysis of rare variants and singletons in the DISC1 Interactome
and Regulome with respect to psychiatric disorders, associated
personality traits, and cognitive variables.
MATERIALS AND METHODS
The materials and methods are described in full in the Supplementary
Information. Briefly, we analyzed 1543 DNA samples comprising 654 cases
(241 SCZ, 221 BD and 192 rMDD) from Scottish hospital patients and 889
Table 1. DISC1 (Number 1) Interactome and Regulome
DISC1 Interactome DISC1 Regulome
AKAP9 KCNQ1 ACTG2 CYB5R2 HNRNPK NSUN6 SORT1
AP4B1 KIF3A ADCY1 DLG2 HOOK3 NUDT1 SOX10
AP4M1 KIFAP3 ADCY3 DLGAP1 HSPA2 NUMBa SRSF6
APP MACF1 AKT1 DMRT2 ID1 OGFR STAT5A
ATF4 MAP1Ab ANKRD16 DTNBP1 IL9R OLIG2 SV2B
ATF5 NDE1 APPL2 DUSP6 ITPR1 OPTN SYN1
ATF7IP NDEL1 ARC DYNLL1 JUNB PAK3 SYN2
CCDC88A OLFM1 ARHGEF11 EEF1E1 KIF5Ca PCBP1 SYP
CDC5L PAFAH1B1 ATP6V0A1 EEF2K LIMA1 PCM1a TACR1
CDK5RAP3 PCNT BANK1 EGR2 LITAF PDE4A TGFBI
CEP290 PDE4B BBS4 EGR3 LPIN1 PITPNM1 THOP1
CITb PDE4D BCRa EGR4 MARCH3 POU6F1 TIMM8A
CLIC1 RAD21 BDNF ERBB2 MCPH1 PPARGC1A TMEM163
CLU RANBP9 BEX2 ERBB3 MDFIC PPP4R2 TNFAIP8L2
CTNNB1 SH3BP5 BLZF1 ERBB4a MEG3 PRKCB TNFRSF11B
DCTN1 SMC3 BRD1a FHIT MGLL PRR18 TP53RK
DCTN2 SNX6 C5orf48 GABBR1 MMP7 PRRC2A TRIOBP
DISC1b SYNE1 CACNA1C GABRA5 MTPAP RAB3A TSNAXIP1a
DIXDC1 TNIK CALM3 GJA5a MYRIP RGS4 TUBB3
DPYSL3 TRAF3IP1 CAMK1D GNB1L NAPB RHOA UBL3
DSTb TRIO CAMK4 GRIA1 NCOR2 RPS6KA2 UQCRC1a
EIF3H TSNAX CCND2 GRIA2a NDN SCHIP1 USP7
EXOC4 TSNAX-DISC1 CCNE1 GRIA3 NEK1 SERPINI1 VASH2
FBXO41 TUBB CETP GRIN1 NFKB2a SKAP1 VPS45
FEZ1 TUBG1 CHMP1A GRIN2Aa NFKBIA SLC17A7 VRK2
GNB1 WNT3A CHRNA5 GRIN2B NOS1 SLC1A2a WDFY1
GRB2 YWHAE CLINT1 GRM3 NOS1AP SLC41A2 XPOT
GRIPAP1 YWHAZ COMMD1 HERPUD1 NOTCH4 SMC1A ZHX2
GSK3B CORO1B HIPK2 NRG1 SNAP91 ZIC1a
ITSN1 CPLX2 HIST1H2BN NRXN1a SNPH ZNF140
KALRN CTTN HLA-DQA1a NRXN3 SORCS3
aGenes with a nominally significant burden p-values for schizophrenia (16 of 154 genes in the DISC1 Regulome). These gene level results did not survive
family-wise error rate correction across all tests. bGenes with a nominally significant burden p-values for cognitive ability at age 11 (4 of 59 genes in the DISC1
Interactome).
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community-dwelling, generally healthy older people from the Lothian Birth
Cohort of 1936 (LBC1936), as described previously.17
A total of 213 genes were selected for sequence analysis (Table 1,
Supplementary Information: gene selection, Supplementary Table S1). The
DISC1 locus (DISC1, TSNAX and TSNAX-DISC1) and 56 direct DISC1 protein-
protein interactors defined the DISC1 Interactome gene set. A total of 154
additional genes related to DISC1 expression from previous microarray
analyzes comprised the DISC1 Regulome gene set. Genomic regions
comprising ~ 11.7 Mb (3.3 Mb exons) were captured using a custom
solution capture probe set (Roche NimbleGen, Pleasanton, CA, USA). Each
sample capture was sequenced using a HiSeq2000 sequencer (Illumina,
San Diego, CA, USA). Sequence reads were aligned to the human NCBI
Build 36 (hg18) reference using BWA.36 Variant calling was performed
using GATK,37 and high-quality SNVs were filtered by standardized filtering
parameters. Using PLINK,38 we applied data quality control filters as
described previously17,39 to exclude samples and SNVs that introduce bias
(Supplementary Figures S2–S5). Sanger sequencing was used to optimize
the quality control filters and exclude all identified false positive SNVs from
further analysis. SNVs were matched to hg19 coordinates using liftOver
from UCSC, and ANNOVAR40 was used for variant annotation based on the
human reference genome hg19 (RefSeq). The coding variants were
grouped into three mutation classes, similar to previous analyses,4,32 based
on predicted functional effects: Disruptive, nonsense and splice site
variants; NSstrict, disruptive plus missense variants predicted as damaging
by all five algorithms (SIFT,41 PolyPhen2 HumDiv and HumVar,42 LRT,43 and
MutationTaster44); NSbroad, disruptive plus missense variants predicted as
damaging by at least one of the algorithms above; NSstrict is therefore a
subset of NSbroad. The burden and accumulation rate of rare variants
(MAFo1%) and singletons in these mutation classes was assessed in each
of the case cohorts and a combined cohort of all diagnoses; and for
cognitive measures: cognitive ability at ages 11 and 70, change in
cognitive ability, crystallized cognitive ability and general cognitive ability;
and personality traits: neuroticism, anxiety and depression (Supplementary
Information: phenotypes). The gene set and gene-wide burden analyses
for all genes containing more than one rare variant were performed using
the R package ‘SKAT’.45 Exact Poisson tests were performed in R to
evaluate the accumulation rates of singletons and rare variants under a
Poisson distribution in cases compared to controls in each functional
mutation class. To control for multiple testing and reduce the risk of false
positives, a bootstrap resampling approach (n=10 000) was used to
estimate the significance of all tests (Family-Wise Error Rate, FWER), taking
into account multiple tests within each diagnosis (FWERwithin) and across
all diagnoses (FWERacross)(Supplementary Information: rare variant burden
analysis).
RESULTS
Targeted sequencing and genetic discovery in 213 DISC1
Interactome and Regulome genes
A total of 1464 samples (95%) were sequenced to a minimum
coverage depth of 20x across at least 80% of the targeted bases
(Supplementary Table S2). Coverage was uniform across all sample
groups (Supplementary Figure S1). Following sequence- and
variant-based quality filters, 196 080 SNVs in 1446 samples (211
cases of SCZ, 169 cases of rMDD, 195 cases of BD, and 871 controls
from the LBC1936) remained for further analyses (Supplementary
Table S2 and Supplementary Figures S2–S5). Of the 196 080 SNVs,
78% have a MAF less than 1%. Only 40% are reported in the 1000
Genome Project European subset (Supplementary Table S3). On
the basis of RefSeq functional annotations using ANNOVAR, 169
905 SNVs mapped to introns, 5410 to 3′ or 5′ UTRs, and 4523 to
coding regions. Of the 4523 exonic variants, 1893 were
functionally classified with respect to coding potential as silent
variants, 2569 as missense, and 41 as nonsense. A further 24 SNVs
were annotated as splice site variants. SNVs showing greater
functional impacts on protein function are more likely to be rare:
100% of nonsense and 92% of splice site variants have MAF o1%,
compared to 79% of silent and 78% of intronic variants.
Analysis of genetic variation in the DISC1 Interactome and
Regulome with psychiatric illness
Rare functional variant analysis in the DISC1 Interactome. There
was no significant burden of rare disruptive, NSstrict or NSbroad
variants in SCZ, BD, or rMDD nor in a combined cohort of all
diagnoses compared to controls in the DISC1 Interactome
(Supplementary Table S6). There was a nominal association of
Figure 1. Gene set burden analysis of rare functional variants for case-control traits. Case-control gene set burden analysis of singletons and
rare variants (MAFo1%) in the DISC1 Interactome (left) and Regulome (right). x-axis represents –log10(P), vertical dashed line: P= 0.05, vertical
solid line: FWERacross P = 0.05; Odds ratio (OR) is labeled for the significant tests with Po0.05. Disruptive mutations, which included nonsense
and splice site variants; NSstrict, Non-synonymous strict damaging mutations which included disruptive variants plus missense variants
predicted as damaging by all five algorithms (PolyPhen2 HumDiv and HumVar, SIFT, LRT and MutationTaster); NSbroad, Non-synonymous broad
damaging mutations which included disruptive plus missense variants predicted as damaging by at least one of the algorithms above.
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fewer rare disruptive variants in SCZ (unadjusted P= 0.0188), but
no significant difference between the accumulation rate of rare
variants for any diagnosis after Family-Wise Error Rate (FWER)
correction (Supplementary Table S7). None of the proportions of
NSstrict and NSbroad rare or singleton variants deviated from the null
hypothesis after FWERacross correction.
The gene-wide burden of non-synonymous coding changes
was nominally, but not significantly increased in psychiatric
disorders (unadjusted P= 0.0048–0.0488) for several DISC1 Inter-
actome genes. None survived correction for multiple testing
(Supplementary Table S8).
Rare functional variant analysis in the DISC1 Regulome. We
analyzed the burden and accumulation rates of rare and singleton
functional variants in the DISC1 Regulome. For SCZ compared to
control samples, we observed a significantly increased burden of
singleton disruptive variants (unadjusted P= 0.0019, FWERwithin
P= 0.0069, FWERacross P= 0.0339, OR= 1.3162, SE = 0.0941; Figure 1
and Supplementary Table S9), and a nominally higher accumula-
tion rate (4.13-fold, unadjusted P= 9.00 × 10− 4, FWERwithin
P= 0.0185, FWERacross P= 0.0965, Supplementary Table S10). In
addition, the accumulation rate of rare disruptive variants, as
opposed to singleton disruptive variants, was 3.47-fold higher in
SCZ cases than in healthy controls and remained significant after
multiple test correction (unadjusted P= 1.68 × 10− 6, FWERwithin
P= 1.00 × 10− 4, FWERacross P= 0.0022, Supplementary Table S10).
Unlike singleton disruptive variants, although the burden of rare
disruptive variants in SCZ was nominally significant, and survived
FWER correction for all tests within the trait, it did not meet the
threshold for tests across all traits (unadjusted P= 0.0061,
FWERwithin P= 0.0228, FWERacross P= 0.0863, Supplementary
Table S9). We also observed a nominally higher proportion and
burden of NSstrict singleton and rare variants in SCZ and disruptive
singleton and rare variants in combined cases compared to
controls, but none survived FWER for all tests across all traits
(Supplementary Tables S9 and S10). There was no evidence for an
increased overall burden in rMDD, BD or combined cases
compared to controls after FWER correction across all traits.
At the gene-wide level, Translin-associated factor X interacting
protein 1 (TSNAXIP1) showed greater burden of NSstrict singletons
in rMDD (unadjusted P= 1.29 × 10− 4, FWERwithin P= 0.0253) and
NSstrict rare variants in SCZ (unadjusted P= 2.22 × 10
− 4, FWERwithin
P= 0.0410, Supplementary Table S11) compared to controls.
However, these results did not survive correction for all tests
(rMDD FWERacross P= 0.0864, SCZ FWERacross P= 0.1600). TSNAXIP1
has 16 exons encoding 712 amino acids. We validated 17 rare
coding variants in TSNAXIP1 in all carriers, including 1 splice site, 1
nonsense and 15 missense variants (Figure 2 and Supplementary
Table S12). Of these 17 rare substitutions, 4 were previously
reported in the 1000 Genomes Project European subset. In total, 7
rare variants in TSNAXIP1 including 2 disruptive and 5 predicted
damaging missense variants contributed to the gene burden
analysis of NSstrict variants in rMDD and SCZ. In a ‘leave-one-out’
approach, we determined that the nonsense mutation at
chr16:66405794 (rs146214814, p.R46X) located in exon 2,
contributed most to the higher burden of NSstrict variants in SCZ.
Relative to controls, this disruptive variant had a 3.58-fold higher
allele frequency in SCZ (0.0146 vs 0.0041) and was not observed in
any other mental illness cohort. Further information on the
neurobiology of TSNAXIP1 is given in Supplementary Information:
TSNAXIP1.
Burden analysis of coding variants on quantitative cognitive ability
and personality traits associated with psychiatric illness
We found that a significantly higher burden of singleton
disruptive variants in the DISC1 Interactome was associated with
lower cognitive ability assessed by Moray House Test (MHT) scores
at age 11 (unadjusted P= 9.35 × 10− 5, FWERwithin P = 0.0005,
FWERacross P = 0.0043, β=− 7.1141, SE = 3.6863; Figure 3 and
Supplementary Table S13). The burden of NSstrict singletons in
the Interactome gene set was associated with lower MHT scores at
age 11 (unadjusted P= 0.0003, FWERwithin P = 0.0017, FWERacross
P= 0.0122, β=− 2.7865, SE = 1.2877). In addition, although these
did not survive FWERacross correction, nominally significant
associations in the burden of disruptive singletons were observed
with MHT scores at age 70 (unadjusted P= 0.0056, β=− 6.6785),
National Adult Reading Test (unadjusted P= 0.0051, β=− 6.9970)
and General Fluid Intelligence (unadjusted P= 0.0293, β=
− 0.5152). Interestingly, there were nominally significant associa-
tions between the burden of rare functional variants and
increased symptoms of neuroticism (Disruptive singletons:
Figure 2. Translin-associated factor X interacting protein 1 (TSNAXIP1) rare functional variants. TSNAXIP1 exon structure and mutations. Definitions
of Disruptive (red), NSstrict (underlined) and NSbroad mutations are given in Figure 1. Neutral variants (green) were defined as missense variants
predicted as not damaging by any of the five predictive algorithms. Dash lines represent the variants present in the European subset of the
1000 Genomes Project (1000G_EU), and the solid lines represent the variants present in the 1000G_EU. The number of circles represents the
number of samples carry the rare variant.
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unadjusted P= 0.0154, β= 6.5671), anxiety (NSstrict rare variants:
unadjusted P= 0.0349, β= 0.1394) and depression (NSbroad single-
tons: unadjusted P= 0.0431, β= 0.2587). At the gene-wide level, no
association was found between the variability in cognitive ability
or personality scores and the burden of damaging or disruptive
variants in any specific gene of the DISC1 Interactome after
FWERacross correction (Supplementary Table S14).
In the analysis of the DISC1 Regulome, we observed a burden of
NSstrict singletons associated with lower MHT scores at age 70
(unadjusted P= 0.0014, β=− 1.7895; Figure 3 and Supplementary
Table S15) that withstood FWER correction for all tests within the
trait (FWERwithin P= 0.0079), but not all tests across all traits
(FWERacross P= 0.0609). The burdens of NSstrict and NSbroad variants
were nominally significantly associated with greater decrease in
cognitive ability between the ages of 11 and 70 (NSstrict singletons:
unadjusted P= 0.0131, β= − 1.4338; NSbroad singletons: unad-
justed P= 0.0014, β= − 0.3175; NSbroad rare variants: unadjusted
P= 0.0280, β= − 0.0010). At the gene-wide level, the strongest
association with cognitive function was observed with rare and
singleton NSstrict variants in CACNA1C, but this did not pass
FWERacross correction (Supplementary Table S16).
DISCUSSION
Encouraging progress towards delineating the genetic architec-
ture of psychiatric disorders has been made and roles for both
common, rare and de novo mutations established. Rare variants of
high impact can provide valuable mechanistic insight. Recent
case-control deep sequencing studies indicate that in individuals
with SCZ rare loss-of-function variants are enriched in genes
related to synaptic function,31 in target genes of the FMPRP32 and
in genes known to be associated with SCZ.46 The biological
impacts of several DISC1 missense variants identified through
deep sequencing have been demonstrated.30,47 We previously
reported the discovery of rare disruptive DISC1 variants in
individuals with psychiatric illness and demonstrated the biologi-
cal impact of the p.R37W variant.17 Here we report the association
of both clinical diagnoses and cognitive ability with rare variants in
the DISC1 Interactome and the DISC1 Regulome.
Before discussing these positive findings, we first consider some
limitations of the study. Although the sample size was large by
current standards, these numbers are modest in size for
comprehensive rare variant detection.17,48 We were unable to
perform sex-specific analyses in our study given our sample size.
Such analyses may be important in our understanding of the
relationships between genetic variants and gene expression
particularly in psychiatric illness, given reports of sex-specific
differences in gene expression in the brain49,50 but also due to
reports of sex-specific differences in association of variants and
haplotypes in DISC1,51–53 the success of the CONVERGE strategy
that relied on mapping loci for severe depression within a female-
only cohort54 and the differences in disease presentation between
sexes that have likewise been reported.55 Burden analysis
increases the power of analyses in such small samples, but the
Figure 3. Gene set burden analysis of rare functional variants for quantitative traits. Quantitative trait gene set burden analysis of singletons
and rare variants (MAFo1%) in the DISC1 Interactome (left) and Regulome (right). x-axis represents –log10(P), vertical dashed line: P = 0.05,
vertical solid line: FWERacross P = 0.05; Effect size (β, Beta) is labeled for the significant tests with Po0.05. See phenotype descriptions in
Supplementary Information for all quantitative traits. Moray House Test is the mental ability test used in the LBC1936 cohort. A priori
hypothesis is that an increased burden of rare predicted damaging variants would reduce scores for cognitive variables and increase scores
for personality traits. The definition of the variant classes is given in Figure 1.
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rules for annotating rare variants as ‘damaging’ are far from
foolproof: biological validation is required. Last, but not least,
whole genome sequencing of all 1543 individuals, while ideal, was
beyond the scope of our resources. Targeted capture sequencing
was a practical option, but it is likely that relevant variants will
have been missed by virtue of poor capture. It is also almost
certainly the case that our list of bona fide DISC1 interactors is
incomplete, and that contra wise, not all members of the
Regulome that met our inclusion criteria will be regulated by
DISC1 in practice.
Acknowledging these limitations, there were findings of note.
No association was seen between rare variants in the DISC1
Interactome and any psychiatric diagnosis. There was, however, a
significant excess of singleton disruptive variants in the DISC1
Regulome associated with SCZ, but not with BD or rMDD. We have
shown that disruptive and NSstrict singleton variants in the DISC1
Interactome show significant association with cognitive ability at
age 11. These classes of variants are also nominally associated in
the DISC1 Regulome with cognitive ability at age 70 and change in
cognitive ability between age 11 and 70. The DISC1 Regulome
gene set was assembled from genes that show both i) altered
expression in response to genetic variation in DISC1 or its
interactors, or are themselves protein interactors of the core
complex, and ii) evidence of association with psychiatric illness
from candidate gene studies, or some of the earliest genome-wide
association studies.1,56,57 We note that in this study, we found
nominal association of rare Regulome variants with both increased
schizophrenia risk and lower adult cognitive ability, particularly in
older age. This mirrors the observation of association with
common variants from the DISC1 Regulome in GWAS
studies.8,9,58,59 Overall, the patterns of associations seen across
diagnostic and cognitive traits in the DISC1 Interactome and
Regulome are consistent with the hypothesis that genetic
disruption of DISC1 or its direct interactors has a proximal
effect on cognitive ability and a distal effect, through regulation of
gene expression, on schizophrenia risk in later life. Indeed, we
have shown previously that disruption of the Disc1 gene in mice
results in altered expression of Nrxn1,33 a gene in which copy
number variation, common variants and rare variants are
associated with schizophrenia.60–62 The hypothesis of a distal
effect of variants in the Interactome on disease risk is also
consistent with the recent association of copy number variants
linked to intellectual disability with schizophrenia in a much
larger sample.63
Four genes in the Interactome gene set, DISC1, CIT, DST and
MAP1A, were nominally associated at the gene level with cognitive
ability at age 11 (Table 1). CIT and MAP1A are known interactors
with DLG4, PSD-95, which in turn interacts with the cytoplasmic
tail of NMDA receptor subunits and with shaker-type potassium
channels, regulating the ratio of excitatory to inhibitory synapses
in the hippocampus.64–66 Because of the complex network
multiplicity of protein interactions identified by the DISC1
Interactome gene set, we cannot conclude that our association
with cognitive ability at age 11 is specific, or restricted to, the
DISC1 Interactome or indeed that this phenotype is the only one
likely to be associated with rare functional variants in this set of
genes. This important caveat also applies not only to the DISC1
Regulome gene set, in which 16 genes were nominally associated
at the gene level with schizophrenia (Table 1), but likely to the
majority of brain-expressed gene sets. None of the gene level
associations survived FWER correction across all tests.
To better understand the distinctive patterns of association
between the DISC1 Interactome and Regulome, and their
relationship to previously published mental health-related gene
sets, we performed gene ontology (GO) enrichment analyses
(Supplementary Tables S17, 18 and Supplementary Figures S9).
The DISC1 Interactome is significantly enriched for proteins
involved in regulation of nervous system development,
microtubule cytoskeleton organization, and vesicle localization
(Supplementary Tables S17, 18 and Supplementary Figures S9).
Our findings suggest that disruptive singletons in these biological
processes may make significant contributions to variability in
cognitive function. These processes have also been associated
with intellectual disability.67 Together, these datasets suggest that
there is a spectrum of effect sizes or penetrance associated with
genetic variants in this pathway. In contrast, the DISC1 Regulome
is enriched for genes involved in synaptic transmission and
glutamate-gated ion channel activity, reflecting the regulation by
the DISC1 Interactome of these processes and their importance as
inferred from GWAS. The specificity of the association between
single disruptive Regulome variants and SCZ in our sample
suggests a greater impact of glutamate dysregulation in this
disorder than BD or rMDD. A role for DISC1 in glutamate-related
processes has previously been suggested in both a mouse model
and in the t(1;11) translocation family.68,69 Comparison of the GO
terms associated with both the DISC1 Interactome and Regulome
reveals largely independent GO term associations with a very
limited set of intersecting terms focused on negative regulation
of cellular process, protein binding, and cell projections
(Supplementary Figures S9).
In conclusion, and despite the limitations, these findings provide
further genetic evidence to support the impact of both DISC1-
interacting proteins and genes whose expression is modulated by
genetic variants in the DISC1 pathway on schizophrenia.
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